harmaSGP is a pharmaceutical company with a broad portfolio of leading, over-the-counter (OTC) drugs and other healthcare products.
Our drugs are based on natural pharmaceutical active ingredients with documented efficacy and have virtually no known side effects. With our pharmacy-exclusive products, we have trusted brands in many relevant chronic indications that are leaders in their respective categories. The herbal-medicine Baldriparan®, is the leading OTC brand in Germany for natural valerian sleep aids. With the brands RubaXX® for rheumatic pain and Restaxil® for neuralgic pain (nerve pain), we are also the market leader for systemic, chemical-free OTC pain relievers.
In addition, the products against sexual weakness, which are marketed under the brands DESEO® and NERADIN®, are the leading chemical-free products in their category in Germany.
Since the launch of the first product from the current portfolio in Germany in 2012, we have successfully exported our business.
Lochhamer Schlag 21, 82166 Gräfelfing – Germany
|Date||Trading entity / Person||Association||Trade type||Volume|
|05.10.22||MMI Leisure & Capital Management GmbH||Close relation||Buy||EUR 125,383.20|
|05.10.22||Hillen, Ingo||Board||Buy||EUR 1,048.00|
|05.10.22||MMI Leisure & Capital Management GmbH||Close relation||Buy||EUR 26.60|
|30.05.22||Wittig, Dr. Thomas||Supervisory board||Buy||EUR 138,953.80|
|30.05.22||Schröter, Jasmin||Close relation||Buy||EUR 119,660.00|
|30.05.22||Simon-Schröter, Dr. Wolfram||Other||Buy||EUR 10,040.00|
|25.04.22||FUTRUE GmbH||Close relation||Buy||EUR 208,180.53|
|25.04.22||MMI Leisure & Capital Management GmbH||Close relation||Sell||EUR 197,193.60|
|25.04.22||Bloching, Prof. Dr. Micha||Supervisory board||Sell||EUR 171,825.00|
|25.04.22||MMI Leisure & Capital Management GmbH||Close relation||Sell||EUR 99.00|
Joh. Berenberg, Gossler & Co. KGListed Stock Exchange
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.